Interview with Luciano Marques, Novartis South Africa
Having spent two months as the head of Novartis South Africa, what is your first assignment as General Manager, could you share with our readers what were the surprises for…
Address: 72-74 Steel Road
Spartan
Kempton Park
Gauteng
1619 South Africa
Tel: +27.11.929.9111
Web: http://www.novartis.co.za/index.asp
Novartis was created in 1996 from the merger of the Swiss companies, Ciba-Geigy and Sandoz. Our name, ‘Novartis’ derived from the latin ‘novae artes’ means ‘new skills’.
In 2006, Novartis celebrated 10 years of helping patients worldwide since the successful creation of a health care leader through the merger. With its headquarters in Basel, Novartis operates in 140 countries and has more than 98 000 employees.
Novartis South Africa embodies Novartis core corporate purpose, which is to ‘Care and Cure’, putting the patient at the centre of all that we do.
Patient centricity is the common theme that runs through our diverse businesses and products represented by, Novartis Pharmaceuticals, Over the Counter Medicines(OTC), Animal Health, Ciba Vision and Sandoz Generics in South Africa.
Having spent two months as the head of Novartis South Africa, what is your first assignment as General Manager, could you share with our readers what were the surprises for…
The General Manager of Abbott’s Established Pharmaceuticals Division in South Africa, Gauta Phillip Mavundla illustrates how he is building the division’s presence within the region after the spinoff of AbbVie,…
Muhammad Bodhania, Managing Director of Medreich South Africa discusses potential strategic implications of the recent acquisition of Medreich by Meiji and the importance of local partnerships for global success. Can…
The CEO of BioTech Africa, Jason Lurie, evaluates the domestic and global landscape for diagnostic recombinant proteins, and highlights other developmental streams that have helped diversify the company’s portfolio. He…
The owner of Altis Biologics, Nick Duneas, illustrates the significance of the company’s flagship product, the Altis Osteogenic Bone Matrix (OBM) and how the company plans to commercialize the injectable bone…
The managing director of Trinity Pharma, Gaby Simaan (Jnr) depicts Trinity’s evolution from a regulatory consultancy into a fully commercialized pharmaceutical company, and how their unique position in the private…
The managing director of Galderma South Africa, Jenny Wright reveals the importance of the dermatology sector within the country’s healthcare system, as well as the role Galderma is playing in…
The Vice-Chairman of the Public Health Enhancement Fund talks about how the shortage of medical doctors and the fight against TB, HIV and AIDS in South Africa led the health…
The Head of the Department of Medicine at the Faculty of Health Science at the University of Cape Town reveals how their role is not only in training people to…
The managing director of Adcock Ingram’s prescription business, Ashley Pearce highlights the division’s strategic placement within the group’s overall activities, and how he plans on leveraging partnerships with various multinationals,…
The general manager of Ferring South Africa, Mercia Van Zyl discusses the company’s ambitious plans for the future under the slogan ‘People come first’, the placement of fertility under the…
The CEO of IPASA reveals how over the last ten months the priority has been to reach out to different stakeholders, rebuilding trust with the department of health, with patients…
The director of MRA Regulatory Consultants, Henriette Vienings reveals the important role they play in helping pharmaceutical companies navigate South Africa’s regulatory environment, as well as the importance of the…
See our Cookie Privacy Policy Here
